DEMYELINATING SENSORIMOTOR, POLYNEUROPATHY AFTER ADMINISTRATION OF FK506

[1] Lopez O.L., Martinez A.J., Torre-Cisneros J., Neuropathologic findings in liver transplantation: A comparative study of cyclosporine and FK506, Transplant Proc, 23, (1991)

[2] Eidelman B.H., Abu-Elmagd K., Wilson J., Et al., Neurologic complications of FK506, Transplant Proc, 23, (1991)

[3] Palmer B.F., Toto R., Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients, Am J Kidney Dis, 18, (1991)

[4] Alessiani M., Cillo U., Fung J.J., Adverse effects of FK506 overdosage after liver transplantation, Transplant Proc, 25, (1993)

[5] Bronster D., Emre S., Mor E., Et al., Neurologic complications of orthotopic liver transplantation, Mount Sinai J Med, 61, 1, (1994)

[6] Walker R.W., Brochstein J.A., Neurologic complications of immu nosuppressive agents, Neurol Clin, 6, (1988)

[7] Wilson J.R., Conwit R.A., Eidelman B.H., Et al., Sensorimotor neuropathy resembling CIDP in patients receiving FK506, Muscle Nerve, 17, (1994)

[8] Pouteil-Noble C., Vial C., Moreau T., Et al., Acute polyradiculoneuritis associated with cytomegalovirus infection in renal transplantation, Clin Transplant, 7, (1993)

[9] Mor E., Schwersenz A., Sheiner P.A., Emre S., Schwartz M.E., Miller C.M., Reversal of gastrointestinal toxicity associated with longterm FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients, Transplantation, 57, (1994)

[10] Freise C.E., Rowley H., Lake J., Et al., Similar clinical presentation of neurotoxicity following FK506 and cyclosporine in a liver transplant recipient, Transplant Proc, 23, (1991)

[1] Lopez O.L., Martinez A.J., Torre-Cisneros J., Neuropathologic findings in liver transplantation: A comparative study of cyclosporine and FK506, Transplant Proc, 23, (1991)

[2] Eidelman B.H., Abu-Elmagd K., Wilson J., Et al., Neurologic complications of FK506, Transplant Proc, 23, (1991)

[3] Palmer B.F., Toto R., Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients, Am J Kidney Dis, 18, (1991)

[4] Alessiani M., Cillo U., Fung J.J., Adverse effects of FK506 overdosage after liver transplantation, Transplant Proc, 25, (1993)

[5] Bronster D., Emre S., Mor E., Et al., Neurologic complications of orthotopic liver transplantation, Mount Sinai J Med, 61, 1, (1994)

[6] Walker R.W., Brochstein J.A., Neurologic complications of immu nosuppressive agents, Neurol Clin, 6, (1988)

[7] Wilson J.R., Conwit R.A., Eidelman B.H., Et al., Sensorimotor neuropathy resembling CIDP in patients receiving FK506, Muscle Nerve, 17, (1994)

[8] Pouteil-Noble C., Vial C., Moreau T., Et al., Acute polyradiculoneuritis associated with cytomegalovirus infection in renal transplantation, Clin Transplant, 7, (1993)

[9] Mor E., Schwersenz A., Sheiner P.A., Emre S., Schwartz M.E., Miller C.M., Reversal of gastrointestinal toxicity associated with longterm FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients, Transplantation, 57, (1994)

[10] Freise C.E., Rowley H., Lake J., Et al., Similar clinical presentation of neurotoxicity following FK506 and cyclosporine in a liver transplant recipient, Transplant Proc, 23, (1991)